stem cell-based assay Johns Hopkins, NYSCF Collaborate on Stem Cell Models of Disease for Precision Medicine The collaborators hope to establish new models of human disease using patient-derived stem cells, with support from Bloomberg Philanthropies. Amarantus Reacquires Neurology Diagnostic Assets from Avant Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary. Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling Evotec will gain non-exclusive rights to Ncardia IP, including a broad panel of stem cell-derived cell lines for use in drug target discovery and testing. Cellular Dynamics International, Nanion Technologies Ink Comarketing Pact The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform. New Studies Demonstrate Utility of iPSC Technology for Genetic Research Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body. Jul 14, 2015 Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP Nov 25, 2014 NIH to Fund Development of New Stem Cell Cytotoxicity Assays Jun 2, 2014 Definigen Closes $3.8M Series A Round Nov 10, 2011 Epistem, Univ. of Manchester Partner on Wound Healing Models Nov 2, 2011 ILS, Stemina Partner on Toxicity Screening Feb 17, 2011 CIT, Stemina Ink Distribution Deal for Stem Cell-based Assay Jun 30, 2010 StemCells to Raise $5.7M in Private Placement Jun 15, 2010 Promega, CDI Collaborate on Stem Cell-Based Drug Toxicity Assays Sep 22, 2009 NCI Team Develops Mouse Stem Cell Assay for Classifying BRCA1 Mutations Breaking News SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.